Fifty children with malignant diseases were vaccinated against hepatitis B. Twenty-nine children suffered from leukaemia or non-Hodgkin's lymphoma; 14 of these were on intensive chemotherapy (group I) and 15 were without intensive therapy (group II). The other 21 children had various forms of solid
Hepatitis B vaccination in children: Persistence of immunity at 9 years
β Scribed by A. Milne; N. Hopkirk; C. D. Moyes
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 127 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A nationwide hepatitis B vaccination program was launched in Taiwan in 1984. To study the impact of this ongoing program on hepatitis B virus (HBV) infection, a follow-up seroepidemiologic study was carried out in 1989 in a Taipei district where pre-vaccination seroepidemiology had been studied. HBV
Six hundred forty-three children, negative for markers of hepatitis B virus (HBV) infections, were given three X 2-micrograms doses of Merck, Sharp and Dohme (MSD) plasma derived hepatitis B vaccine (H-B-Vax) at monthly intervals. Twelve months after the first dose of vaccine, antibody to hepatitis
## Abstract A combined hepatitis A and B vaccine is available since 1996. Two separate openβlabel primary studies evaluated the immunogenicity and safety of this hepatitis A and B vaccine (720βEI.U of HAV and 20βΒ΅g of HBsAg) in 306 healthy subjects aged 17β43 years who received three doses of the v
## Abstract Longβterm persistence of vaccineβinduced immune response in adults was assessed annually for 15 years following primary immunization with a twoβdose inactivated hepatitis A vaccine. In 1992, 119 and 194 subjects aged 17β40 years and naΓ―ve for hepatitis A virus (HAV) were enrolled in two
Abbreviations: HBsAg, hepatitis B surface antigen; anti-HBs, hepatitis B surface antimonths. 2 From the 415 children, we recruited 16 chronically infected gen antibody; HBV, hepatitis B virus; PCR, polymerase chain reaction; PBMC, peripheral children who had cleared serum HBsAg for more than 2 years